Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
24.12
+0.29 (1.22%)
At close: Jul 3, 2025, 1:00 PM
22.88
-1.24 (-5.14%)
After-hours: Jul 3, 2025, 4:33 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $266.66 million as of July 3, 2025.
Market Cap
266.66M
Enterprise Value
204.19M
1-Year Change
n/a
Ranking
Category
Stock Price
$24.12
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $266.66M, an increase of 85.22%. That is a compound annual growth rate of 209.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 266.66M | 98.03% |
| Dec 31, 2024 | 134.66M | -6.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |